Clinical-epidemiological characteristics of cervical cancer at Erasmo Meoz Hospital between 2015-2020
DOI:
https://doi.org/10.24054/cbs.v1i2.2631Keywords:
Cancer, Human Papillomavirus, Mass ScreeningAbstract
Objective: To identify the clinical-epidemiological characteristics of patients at HUEM (ERASMO MEOZ UNIVERSITY HOSPITAL) with cervical cancer in the period 2015 - 2020 in relation to the public health strategies of vaccination and screening. Justification: cervical cancer in Colombia is the leading cause of cancer death among women aged 30 to 59 years and worldwide it is the 4th most frequent type of cancer in women with 604,000 new cases each year and 342,000 deaths per year, thus being an important pathology that must be characterized by its population and its clinical-epidemiological characteristics in the region. Methodology: an observational-descriptive research was carried out, whose sample was made up of a total of 212 patients whose inclusion criteria consisted of being gynecological oncological patients in the HUEM with cervical cancer in the period 2015 – 2020 with ages between 20 and 50 years, and whose exclusion criteria were having died and not being in the age range of 20-50 years, The study variables were: age, vaccination status, screening, age at the beginning of sexual intercourse, use or not of protection methods, diagnosis and treatment. Results: 132 patients were vaccinated against HPV, 117 were screened, 116 did not use barrier methods in sexual intercourse, 118 patients were diagnosed with Malignant Tumor of the Exocervix (C531) and 56 with Malignant Tumor of the Endocervix (C530), with respect to treatment according to the number of patients in each scheme are: 35 in surgery, 35 in radiotherapy, 30 in chemotherapy, 27 in chemotherapy plus radiotherapy, 16 in palliative care and 31 without treatment
Downloads
References
Instituto nacional de salud. (n.d.). Vacunación contra el Virus Papiloma humano - VPH en Colombia, para la prevención del cáncer de cuello uterino y verrugas genitales. Documento Informativo para personal del área de la salud. www.minsalud.gov.c. https://minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/IA/INCA/1-vacunacion-contra-virus-papiloma%20humano-verrugas-genitales.pdf
Instituto nacional de salud. (2018, July). Cáncer de mama y cuello uterino Vigilancia epidemiológica. Semana epidemiológica 23 junio 03 al 09 de 2018. Boletín epidemiológico. https://www.ins.gov.co/buscador-eventos/Paginas/Vista-Boletin-Epidemilogico.aspx
Ministerio de salud y protección social, Cáncer de cuello uterino. Bogotá. S.f. https://www.minsalud.gov.co/salud/publica/ssr/Paginas/Cancer-de-cuello-uterino.aspx
Organización mundial de la salud. (2022, January 20). Cáncer Cervicouterino. World Health Organization. https://www.who.int/es/news-room/fact-sheets/detail/cervical-cancer
Sanchez, J. D. (2018, December 12). OPS/OMS: Virus del papiloma humano (VPH). Pan American Health Organization / World Health Organization. https://www3.paho.org/hq/index.php?option=com_content&view=article&id=14873%3Asti-human-papilloma-virus-hpv&Itemid=0&lang=es#gsc.tab=0
Toziano, M., Gogorza, S., & Daguerre, P. (2022). Nueva guía 2022 Prevención primaria y secundaria del cáncer cervicouterino: “Manejo del tamizaje anormal y de las lesiones histológicas del cuello uterino.” ARGENTINA; COLPOARGENTINA.
Vacuna contra el virus del Papiloma Humano (VPH). Vacuna contra el Virus del Papiloma Humano (VPH) | OPS/OMS | Organización Panamericana de la Salud. (n.d.). https://www.paho.org/es/vacuna-contra-virus-papiloma-humano-vph
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista Ciencias Básicas en Salud
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.